<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on July 28, 2020</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT03936673</url>
  </required_header>
  <id_info>
    <org_study_id>2014/349</org_study_id>
    <nct_id>NCT03936673</nct_id>
  </id_info>
  <brief_title>Effect of Nephrostomy on Relative Function of Obstructed Kidney</brief_title>
  <official_title>The Effect of Percutaneous Nephrostomy Application on Obstructed Kidneys With Relative Function of 10% or Less In Technetium-99m Dimercaptosuccinic Acid (DMSA) Scintigraphy</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>TC Erciyes University</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
  </sponsors>
  <source>TC Erciyes University</source>
  <oversight_info>
    <has_dmc>No</has_dmc>
    <is_fda_regulated_drug>No</is_fda_regulated_drug>
    <is_fda_regulated_device>No</is_fda_regulated_device>
  </oversight_info>
  <brief_summary>
    <textblock>
      Urinary tract obstruction is a serious health problem due to kidney damage. Relative renal
      function has an important role in the treatment of obstructed kidneys. Nephrectomy can be
      recommended when the relative renal function is 10% or less in radionuclide examinations.
      Recently, however, nephron sparing approaches have come to the fore. This indicated the need
      to evaluate the possibility of recovering the function of the kidney before nephrectomy. The
      aim of this study is to compare relative functions of obstructed kidneys in technetium 99m
      dimercaptosuccinic acid scintigraphy (DMSA) before and 2 weeks after nephrostomy tube.
    </textblock>
  </brief_summary>
  <detailed_description>
    <textblock>
      Obstructive uropathy is one of the most important causes of acute renal injury and end-stage
      renal failure. obstruction of urine flow increases the intratubular pressure. This pressure
      increase causes decrease in renal blood flow and starts the inflammatory process. In the
      first few hours after total ureter obstruction, due to the increase in intratubular pressure
      glomerular filtration ceases and tubular transport is markedly decreased. Long lasting
      obstruction results in renal fibrosis and end stage renal damage. Basically obstructive
      uropathy leading to irreversible renal damage and loss of renal function is the main
      indication for simple nephrectomy. Serious renal parenchymal damage is defined as
      non-functioning kidney having relative renal function (RRF) 10% or less in the literature.
      But recently in some studies it was suggested that by applying the nephrostomy catheter,
      ability of kidney to regain function can be evaluated before nephrectomy. So, possibility of
      gaining function should be kept in mind. In this study effect of percutaneous nephrostomy
      tube on serum creatinine, blood urea nitrogen (BUN) and RRF in obstructed kidney with RRF 10%
      or less. Before and 2 weeks after percutaneous nephrostomy, serum creatinine, ure and RRF in
      DMSA was recorded and compared.
    </textblock>
  </detailed_description>
  <overall_status>Completed</overall_status>
  <start_date type="Actual">July 1, 2014</start_date>
  <completion_date type="Actual">January 1, 2019</completion_date>
  <primary_completion_date type="Actual">May 31, 2018</primary_completion_date>
  <phase>N/A</phase>
  <study_type>Interventional</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <allocation>N/A</allocation>
    <intervention_model>Single Group Assignment</intervention_model>
    <intervention_model_description>Patients diagnosed with unilateral obstructed kidney with RRF 10% or less underwent application of percutaneous nephrostomy tube on affected side.</intervention_model_description>
    <primary_purpose>Treatment</primary_purpose>
    <masking>None (Open Label)</masking>
  </study_design_info>
  <primary_outcome>
    <measure>serum creatinine level 2 weeks after nephrostomy</measure>
    <time_frame>2 weeks after nephrostomy</time_frame>
    <description>serum creatinine level 2 weeks after nephrostomy</description>
  </primary_outcome>
  <primary_outcome>
    <measure>Serum BUN level 2 weeks after nephrostomy</measure>
    <time_frame>2 weeks after nephrostomy</time_frame>
    <description>Serum BUN level 2 weeks after nephrostomy</description>
  </primary_outcome>
  <primary_outcome>
    <measure>RRF in DMSA 2 weeks after nephrostomy</measure>
    <time_frame>2 weeks after nephrostomy</time_frame>
    <description>RRF in DMSA 2 weeks after nephrostomy</description>
  </primary_outcome>
  <number_of_arms>1</number_of_arms>
  <enrollment type="Actual">18</enrollment>
  <condition>Obstructive Uropathy</condition>
  <arm_group>
    <arm_group_label>atrophic kidney</arm_group_label>
    <arm_group_type>Experimental</arm_group_type>
    <description>Patients diagnosed with unilateral obstructed kidney with RRF 10% or less underwent application of percutaneous nephrostomy tube on affected side.</description>
  </arm_group>
  <intervention>
    <intervention_type>Procedure</intervention_type>
    <intervention_name>Percutaneous nephrostomy</intervention_name>
    <arm_group_label>atrophic kidney</arm_group_label>
  </intervention>
  <eligibility>
    <criteria>
      <textblock>
        Inclusion Criteria:

          -  Unilateral obstructed kidney with RRF 10% or less

          -  Unilateral obstructed kidney with grade 2 or more hydroureteronephrosis

          -  Defined etiology for unilateral obstructed kidney

          -  estimated glomerular filtration rate (GFR) â‰¥ 30ml/min

          -  Approving the nephrostomy procedure

        Exclusion Criteria:

          -  Unilateral obstructed kidney with RRF above 10%

          -  Estimated GFR &lt;30 ml/min

          -  diagnosis of bilateral obstructed kidneys

          -  not approving nephrostomy
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>18 Years</minimum_age>
    <maximum_age>75 Years</maximum_age>
    <healthy_volunteers>No</healthy_volunteers>
  </eligibility>
  <overall_official>
    <last_name>Abdullah T Demirtas, Assoc Prof</last_name>
    <role>Principal Investigator</role>
    <affiliation>Erciyes University Faculty of Medicine</affiliation>
  </overall_official>
  <location>
    <facility>
      <name>Department of Urology, Ercieys University, Faculty Of Medicine,</name>
      <address>
        <city>Kayseri</city>
        <zip>38039</zip>
        <country>Turkey</country>
      </address>
    </facility>
  </location>
  <location_countries>
    <country>Turkey</country>
  </location_countries>
  <reference>
    <citation>Thorup J, Jokela R, Cortes D, Nielsen OH. The results of 15 years of consistent strategy in treating antenatally suspected pelvi-ureteric junction obstruction. BJU Int. 2003 Jun;91(9):850-2.</citation>
    <PMID>12780846</PMID>
  </reference>
  <reference>
    <citation>Gupta DK, Chandrasekharam VV, Srinivas M, Bajpai M. Percutaneous nephrostomy in children with ureteropelvic junction obstruction and poor renal function. Urology. 2001 Mar;57(3):547-50.</citation>
    <PMID>11248637</PMID>
  </reference>
  <reference>
    <citation>Ismail A, Elkholy A, Zaghmout O, Alkadhi A, Elnaggar O, Khairat A, Elhassanat H, Mosleh A, Hamad B, Elzomer J, Elkaabi A. Postnatal management of antenatally diagnosed ureteropelvic junction obstruction. J Pediatr Urol. 2006 Jun;2(3):163-8. doi: 10.1016/j.jpurol.2005.07.005. Epub 2005 Aug 26.</citation>
    <PMID>18947602</PMID>
  </reference>
  <reference>
    <citation>Morduchowicz G, Winkler J, Zabludowski JR, Boner G. Effects of residual renal function in haemodialysis patients. Int Urol Nephrol. 1994;26(1):125-31.</citation>
    <PMID>8026917</PMID>
  </reference>
  <reference>
    <citation>Wang AY, Wang M, Woo J, Law MC, Chow KM, Li PK, Lui SF, Sanderson JE. A novel association between residual renal function and left ventricular hypertrophy in peritoneal dialysis patients. Kidney Int. 2002 Aug;62(2):639-47.</citation>
    <PMID>12110029</PMID>
  </reference>
  <reference>
    <citation>Bargman JM, Thorpe KE, Churchill DN; CANUSA Peritoneal Dialysis Study Group. Relative contribution of residual renal function and peritoneal clearance to adequacy of dialysis: a reanalysis of the CANUSA study. J Am Soc Nephrol. 2001 Oct;12(10):2158-62.</citation>
    <PMID>11562415</PMID>
  </reference>
  <results_reference>
    <citation>Zhang S, Zhang Q, Ji C, Zhao X, Liu G, Zhang S, Li X, Lian H, Zhang G, Guo H. Improved split renal function after percutaneous nephrostomy in young adults with severe hydronephrosis due to ureteropelvic junction obstruction. J Urol. 2015 Jan;193(1):191-5. doi: 10.1016/j.juro.2014.07.005. Epub 2014 Jul 9.</citation>
    <PMID>25014578</PMID>
  </results_reference>
  <results_reference>
    <citation>Aziz MA, Hossain AZ, Banu T, Karim MS, Islam N, Sultana H, Alam MI, Hanif A, Khan AR. In hydronephrosis less than 10 % kidney function is not an indication for nephrectomy in children. Eur J Pediatr Surg. 2002 Oct;12(5):304-7.</citation>
    <PMID>12469255</PMID>
  </results_reference>
  <verification_date>May 2019</verification_date>
  <study_first_submitted>May 1, 2019</study_first_submitted>
  <study_first_submitted_qc>May 1, 2019</study_first_submitted_qc>
  <study_first_posted type="Actual">May 3, 2019</study_first_posted>
  <last_update_submitted>May 1, 2019</last_update_submitted>
  <last_update_submitted_qc>May 1, 2019</last_update_submitted_qc>
  <last_update_posted type="Actual">May 3, 2019</last_update_posted>
  <responsible_party>
    <responsible_party_type>Principal Investigator</responsible_party_type>
    <investigator_affiliation>TC Erciyes University</investigator_affiliation>
    <investigator_full_name>Abdullah Demirtas</investigator_full_name>
    <investigator_title>Md, Assoc Prof</investigator_title>
  </responsible_party>
  <keyword>obstructive uropathy</keyword>
  <keyword>relative renal function</keyword>
  <keyword>DMSA</keyword>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Urologic Diseases</mesh_term>
  </condition_browse>
  <patient_data>
    <sharing_ipd>No</sharing_ipd>
  </patient_data>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

